Research Article
BibTex RIS Cite

Androgenetik Alopesi Şiddeti ve Vücut Kitle İndeksi Arasındaki İlişkinin Değerlendirilmesi

Year 2018, Volume: 51 Issue: 3, 193 - 195, 26.12.2018

Abstract

AMAÇ:  Bu
çalışmanın amacı, androgenetik alopesi (AGA) şiddeti ile vücut kitle indeksi (VKİ)
arasında bir ilişki bulunup bulunmadığını değerlendirmektir.



GEREÇ VE
YÖNTEMLER:
Bu çalışmaya Sağlık Bilimleri
Üniversitesi Ankara Eğitim ve Araştırma Hastanesi Dermatoloji Kliniği’ne AGA
tanısı ile başvuran toplam 132 hasta dahil edildi. Çalışmaya alınan AGA’lı
erkek hastalar Hamilton-Norwood Sınıflaması’ndaki (HNS) alopesi şiddetine göre
3 gruba ayrıldı: grup 1 ( HNS Tip 1 ve 2), grup 2 (HNS Tip 3-4-5) ve grup 3
(HNS Tip 6-7). Hasta yaşı ve VKİ değerleri gruplar arasında karşılaştırıldı.
Hastalardan çalışma için onam alındı.



BULGULAR: Hastaların yaş ortalaması 45.62±16.09 olarak
bulundu. Ortalama VKİ değeri ise 24.62±1.74 olarak bulundu. Grup 1,2 ve 3’te
sırasıyla 40, 46 ve 46 hasta bulunmaktaydı. Grup 1, 2 ve 3’teki ortanca VKİ
değerleri sırasıyla, 24.30, 24.70 ve 24.25 olarak bulundu. Grup 1, 2 ve 3’teki
ortanca yaş değerleri sırasıyla,  27.5,
45 ve 64.5 olarak bulundu. Androgenetik alopesi şiddeti ile VKİ arasında
istatistiksel olarak anlamlı ilişki bulunamadı (p=0.70).



SONUÇ: Bu çalışmada AGA şiddeti ile VKİ arasında bir
ilişki olmadığı görülmüştür. 

References

  • 1. Chumlea WC, Rhodes T, Girman CJ et al. Family history and risk of hair loss. Dermatology. 2004;209(1):33-9.
  • 2. Kutlubay Z, Baglam S, Engin B, Serdaroglu S. Male androgenetic alopecia. Turkderm. 2014;48(Suppl 1):36-39.
  • 3. Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002 Nov 19;4(22):1-11.
  • 4. Kim BJ, Kim JY, Eun HC, Kwon OS, Kim MN, Ro BI. Androgenetic alopecia in adolescents: a report of 43 cases. J Dermatol. 2006 Oct;33(10):696-9.
  • 5. Rossi A, Anzalone A, Fortuna MC, Caro G, Garelli V, Pranteda G, et al. Multi‐therapies in androgenetic alopecia: Review and clinical experiences. Dermatol Ther. 2016 Nov;29(6):424-432. 6. Küster W, Happle R. The inheritance of common baldness: two B or not two B? J Am Acad Dermatol. 1984;11(5):921-6.
  • 7. Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359-65.
  • 8. Blair SN, Nichaman MZ, editors. The public health problem of increasing prevalence rates of obesity and what should be done about it. Mayo Clin Proc. 2002: Elsevier.
  • 9. Segula D. Complications of obesity in adults: a short review of the literature. Malawi Med J. 2014;26(1):20-4.
  • 10. Yang C-C, Hsieh F-N, Lin L-Y, Hsu C-K, Sheu H-M, Chen W. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study. J Am Acad Dermatol. 2014 Feb;70(2):297-302.
  • 11. Ozbas Gok S, Akin Belli A, Dervis E. Is there really relationship between androgenetic alopecia and metabolic syndrome? Dermatol Res Pract. 2015;2015.12. Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol. 2002 Dec 30;198(1-2):89-95.
  • 13. Imperato-McGinley J, Zhu Y-S. Androgens and male physiology the syndrome of 5α-reductase-2 deficiency. Mol Cell Endocrinol. 2002;198(1-2):51-9.14. Nyholt DR, Gillespie NA, Heath AC, Martin NG. Genetic basis of male pattern baldness. J Invest Dermatol. 2003 Dec;121(6):1561-4.
  • 15. Rebora A. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue. Arch Dermatol. 2001;137(7):943-7.
  • 16. Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol. 2010;63(3):420-9.
  • 17. Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17(3):220-2.
  • 18. Matilainen V, Koskela P, Keinänen-Kiukaanniemi S. Early androgenetic alopecia -as a marker of insulin resistance. Lancet. 2000;356(9236):1165-6.
  • 19. Hirsso P, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health. 2006;14(2).
  • 20. Nam S, Lee E, Kim K, Cha B, Song Y, Lim S, et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord. 1997;21(5):355.
  • 21. Kamycheva E, Berg V, Jorde R. Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects. Endocrine. 2013;43(2):412-8.
  • 22. Su LH, Chen TH. Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey. Arch Dermatol. 2007;143(11):1401-6.
Year 2018, Volume: 51 Issue: 3, 193 - 195, 26.12.2018

Abstract

References

  • 1. Chumlea WC, Rhodes T, Girman CJ et al. Family history and risk of hair loss. Dermatology. 2004;209(1):33-9.
  • 2. Kutlubay Z, Baglam S, Engin B, Serdaroglu S. Male androgenetic alopecia. Turkderm. 2014;48(Suppl 1):36-39.
  • 3. Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002 Nov 19;4(22):1-11.
  • 4. Kim BJ, Kim JY, Eun HC, Kwon OS, Kim MN, Ro BI. Androgenetic alopecia in adolescents: a report of 43 cases. J Dermatol. 2006 Oct;33(10):696-9.
  • 5. Rossi A, Anzalone A, Fortuna MC, Caro G, Garelli V, Pranteda G, et al. Multi‐therapies in androgenetic alopecia: Review and clinical experiences. Dermatol Ther. 2016 Nov;29(6):424-432. 6. Küster W, Happle R. The inheritance of common baldness: two B or not two B? J Am Acad Dermatol. 1984;11(5):921-6.
  • 7. Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359-65.
  • 8. Blair SN, Nichaman MZ, editors. The public health problem of increasing prevalence rates of obesity and what should be done about it. Mayo Clin Proc. 2002: Elsevier.
  • 9. Segula D. Complications of obesity in adults: a short review of the literature. Malawi Med J. 2014;26(1):20-4.
  • 10. Yang C-C, Hsieh F-N, Lin L-Y, Hsu C-K, Sheu H-M, Chen W. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study. J Am Acad Dermatol. 2014 Feb;70(2):297-302.
  • 11. Ozbas Gok S, Akin Belli A, Dervis E. Is there really relationship between androgenetic alopecia and metabolic syndrome? Dermatol Res Pract. 2015;2015.12. Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol. 2002 Dec 30;198(1-2):89-95.
  • 13. Imperato-McGinley J, Zhu Y-S. Androgens and male physiology the syndrome of 5α-reductase-2 deficiency. Mol Cell Endocrinol. 2002;198(1-2):51-9.14. Nyholt DR, Gillespie NA, Heath AC, Martin NG. Genetic basis of male pattern baldness. J Invest Dermatol. 2003 Dec;121(6):1561-4.
  • 15. Rebora A. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue. Arch Dermatol. 2001;137(7):943-7.
  • 16. Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol. 2010;63(3):420-9.
  • 17. Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17(3):220-2.
  • 18. Matilainen V, Koskela P, Keinänen-Kiukaanniemi S. Early androgenetic alopecia -as a marker of insulin resistance. Lancet. 2000;356(9236):1165-6.
  • 19. Hirsso P, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health. 2006;14(2).
  • 20. Nam S, Lee E, Kim K, Cha B, Song Y, Lim S, et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord. 1997;21(5):355.
  • 21. Kamycheva E, Berg V, Jorde R. Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects. Endocrine. 2013;43(2):412-8.
  • 22. Su LH, Chen TH. Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey. Arch Dermatol. 2007;143(11):1401-6.
There are 19 citations in total.

Details

Primary Language Turkish
Journal Section Original research article
Authors

Efsun Tanacan 0000-0003-1975-7460

Nermin Karaosmanoğlu

Ömer Kutlu

Hatice Meral Ekşioğlu This is me

Publication Date December 26, 2018
Submission Date October 25, 2018
Published in Issue Year 2018 Volume: 51 Issue: 3

Cite

AMA Tanacan E, Karaosmanoğlu N, Kutlu Ö, Ekşioğlu HM. Androgenetik Alopesi Şiddeti ve Vücut Kitle İndeksi Arasındaki İlişkinin Değerlendirilmesi. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi. December 2018;51(3):193-195.